Cargando…

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

Detalles Bibliográficos
Autores principales:	Dębniak, Tadeusz, Cybulski, Cezary, Kurzawski, Grzegorz, Górski, Bohdan, Huzarski, Tomasz, Byrski, Tomasz, Gronwald, Jacek, Suchy, Janina, Masojć, Bartłomiej, Mierzejewski, Marek, Lener, Marcin, Teodorczyk, Urszula, Mędrek, Krzysztof, Złowocka, Elżbieta, Grabowska-Kłujszo, Ewa, Nej-Wołosiak, Katarzyna, Szymańska, Anna, Szymańska-Pasternak, Jolanta, Matyjasik, Joanna, Wetering, Thierry van de, Jakubowska, Anna, Oszurek, Oleg, Tołoczko-Grabarek, Aleksandra, Castaneda, Jennifer, Scott, Rodney, Narod, Steven A, Lubiński, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401922/ https://www.ncbi.nlm.nih.gov/pubmed/20223005 http://dx.doi.org/10.1186/1897-4287-4-1-52

Ejemplares similares

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs
por: Lubiński, Jan, et al.
Publicado: (2005)

DNA testing for variants conferring low or moderate increase in the risk of cancer
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

Population Screening for Cancer Family Syndromes in the West Pomeranian Region of Poland
por: Gronwald, Jacek, et al.
Publicado: (2006)

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility
por: Trubicka, Joanna, et al.
Publicado: (2010)

Coverage of the Genetic Background of Breast Cancer in the Polish Population
por: Serrano-Fernández, Pablo, et al.
Publicado: (2006)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
por: Dębniak, Tadeusz, et al.
Publicado: (2015)

Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
por: Huzarski, Tomasz, et al.
Publicado: (2006)

Survival of bladder or renal cancer in patients with CHEK2 mutations
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
por: Ogrodniczak, Alicja, et al.
Publicado: (2022)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Folic acid and cancer risk in BRCA1 carriers
por: Durda, Katarzyna, et al.
Publicado: (2012)

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
por: Gronwald, J, et al.
Publicado: (2009)

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet
por: Lubiński, J, et al.
Publicado: (2012)

Smoking Related Cancers and Loci at Chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish Population
por: Jaworowska, Ewa, et al.
Publicado: (2011)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
por: Gronwald, Jacek, et al.
Publicado: (2023)

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk
por: Suchy, Janina, et al.
Publicado: (2008)

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland
por: Jakubowska, Anna, et al.
Publicado: (2010)

BRCA1 founder mutations compared to ovarian cancer in Belarus
por: Savanevich, Alena, et al.
Publicado: (2014)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)

Copper as diagnostic marker of cancers
por: Muszyńska, Magdalena, et al.
Publicado: (2015)

Magnesium as a diagnostic marker of cancer
por: Marciniak, Wojciech, et al.
Publicado: (2015)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
por: Byrski, T, et al.
Publicado: (2012)

Selenium as diagnostic marker of cancers
por: Jaworska-Bieniek, Katarzyna, et al.
Publicado: (2015)

Zinc as diagnostic marker of cancers
por: Kaczmarek, Katarzyna, et al.
Publicado: (2015)

Iron as diagnostic marker of cancer
por: Sukiennicki, Grzegorz, et al.
Publicado: (2015)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
por: Byrski, T, et al.
Publicado: (2011)

Bladder cancer survival in patients with NOD2 or CDKN2A variants
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
por: Byrski, Tomasz, et al.
Publicado: (2015)

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer
por: Byrski, Tomasz, et al.
Publicado: (2012)

Cisplatin in breast cancer treatment in BRCA1 carriers
por: Gronwald, Jacek, et al.
Publicado: (2012)

Serum selenium level and cancer risk: a nested case-control study
por: Narod, Steven A., et al.
Publicado: (2019)

Blood arsenic levels and the risk of familial breast cancer in Poland
por: Marciniak, Wojciech, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qogjo0obarko9l2dc5sqc9019v